During the Shanghai International Biopharmaceutical Industry Week, experts, scholars, and corporate executives discussed these topics

On October 16th, the opening event of the 2023 Shanghai International Biopharmaceutical Industry Week was held at the Zhangjiang Science Hall in Shanghai.At the event site, discussions were held among participants on topics such as innovation internationalization and industrial internationalization, industrial agglomeration development, and the establishment of ecological service systems

On October 16th, the opening event of the 2023 Shanghai International Biopharmaceutical Industry Week was held at the Zhangjiang Science Hall in Shanghai.

At the event site, discussions were held among participants on topics such as innovation internationalization and industrial internationalization, industrial agglomeration development, and the establishment of ecological service systems.

At the 2023 Shanghai International Biopharmaceutical Industry Week, representatives present shared their insights and insights. Pengpai News Reporter Yu Kaitu

Professor Lu Bai from the School of Pharmacy at Tsinghua University analyzed the ecological system construction of the biopharmaceutical industry by deeply integrating the innovation chain and talent chain. He takes original new drugs as an example, and cross-border cooperation and collaborative innovation in different fields bring new changes in research models, methods, and tools; Universities, research institutions, hospitals, enterprises, and others have established public service platforms to assist in the entire process from basic research to transformational research, and then to application, creating a new ecosystem of "industry university research medicine".

Wu Xiaobin, Global President and Chief Operating Officer of Baekje Shenzhou, proposed that building a global large-scale pharmaceutical company cannot do without pioneering new drugs and the best in class innovation. By laying out a global innovation ecosystem in key node cities represented by Shanghai, it not only benefits the development of the enterprise itself, but also deepens industrial cooperation and helps the high-quality development of Shanghai's biopharmaceutical industry.

Regarding the topic of empowering the innovation chain of the industry chain through the capital chain, Song Kun, the general manager of E Fund Asset Management Co., Ltd., introduced his experiences and thoughts on becoming a professional ecosystem service provider, and particularly praised the "Shanghai Biomedical Industry Investment Promotion Partnership Plan" released in the first half of this year. He stated that this plan proposes a "one-stop service" for investment promotion of biopharmaceutical enterprises, which is playing a positive role in building a world-class "biopharmaceutical circle of friends" in Shanghai.

Disclaimer: The content of this article is sourced from the internet. The copyright of the text, images, and other materials belongs to the original author. The platform reprints the materials for the purpose of conveying more information. The content of the article is for reference and learning only, and should not be used for commercial purposes. If it infringes on your legitimate rights and interests, please contact us promptly and we will handle it as soon as possible! We respect copyright and are committed to protecting it. Thank you for sharing.(Email:[email protected])